Where does Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. ranks #44,272 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s Innovation Score?

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. has an Innovation Score of 28.6 out of 100 (28th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s patent grant rate increasing or decreasing?

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s patents?

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.

Q: How is the Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ústav ranks #44,272 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#44,272
of 49,997 US assignees by volume: 28th percentile
by Innovation Score (28.6/100): 15.3
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44272 · Foreign Corporation #44,272 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #44,272/49,997
PHOTO-FINISH “NEXTGEN”
CPC-NARROW C07K · 7 areas
INNOV-THIN 28.6/100
CLAIMS-RICH 15.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: “NEXTGEN” Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ústav’s 28.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (23%) Velocity 3.3 pts (12%) Breadth 9.4 pts (33%) Claim depth 9.2 pts (32%)

Qualcomm Incorporated · highest

85
Ústav organické… · this assignee

29
3D Lighting… · lowest

7

What this shows Ústav's Innovation Score is 28.6/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ústav?

Each dot is one of Ústav’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ústav’s own 15.3 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ústav vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ústav's grants concentrate

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2019. By volume, Ústav sits between pH Pharma Co., Ltd. and 0912139 B.C. Ltd..

Ústav's three-year grant acceleration

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

ph Pharma

6
v Personalize

6
voestalpine Bohle…

6
x2 Power

6
“Nextgen”

6
Ústav organické c… ◀

6
!OBAC

5
0776425 B C

5
0912139 B C

5

What this shows Ústav holds 6 patents at rank #44,273, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ústav

By rank, the assignees closest to #44,273 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Ústav's primary technology class.

Ústav's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 28th percentile higher than 28% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	16.7%
2020	2	33.3%
2021	1	16.7%
2023	1	16.7%
2024	1	16.7%

Which technologies does Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. patent most?

C07K - Peptides 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C07D - Heterocyclic Compounds 4

C07C - Acyclic OR Carbocyclic Compounds 4

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s patent record in context - here's where to go next.

Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #44,272 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. against pH Pharma Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.